Pallab Kalita
Papers
1
Total Citations
6
H-Index
1
About
Dr. Pallab Kalita is a pioneering researcher at the forefront of nanomedicine and cancer therapeutics, with a specialized focus on the biomedical applications of two-dimensional nanomaterials. His most impactful work centers on transition metal dichalcogenides (TMDs), particularly their revolutionary potential in targeted cancer therapy. In his highly cited 2024 paper, "The futuristic applications of transition metal dichalcogenides for cancer therapy," Dr. Kalita addresses a critical challenge in oncology: the collateral damage to healthy cells caused by conventional treatments. He systematically demonstrates how TMD-based nanoplatforms can overcome this limitation through precise, selective targeting of malignant cells while sparing normal tissue. This seminal work, already garnering 6 citations shortly after publication, establishes a comprehensive framework for next-generation anticancer strategies. Dr. Kalita’s contributions are particularly notable for bridging materials science and clinical oncology, offering a roadmap for developing safer, more effective therapies that could fundamentally change how we approach genetic mutation-driven cancers. His research represents a vital step toward personalized nanomedicine, where engineered nanomaterials can be tailored to individual tumor profiles.
Research Focus
Key Achievements
Top Papers
- 1